Taken together, concomitant reduction of various enzymes involved in choline/methionine metabolism, particularly PNPLA7 whose expression level is markedly reduced in most HCC patients, could be a novel diagnostic marker of this disease. This evidence concerns the gene PNPLA7 and hepatocellular carcinoma.